Cross-interaction between JC virus agnoprotein and human immunodeficiency virus type 1 (HIV-1) Tat modulates transcription of the HIV-1 long terminal repeat in glial cells

Journal of Virology

Volumn 80, Issue 18, 2006, Pages 9288-9299

  Kaniowska, Dorota ^a   Kaminski, Rafal ^a   Amini, Shohreh ^a   Radhakrishnan, Sujatha ^a   Rappaport, Jay ^a   Johnson, Edward ^b   Khalili, Kamel ^a   Del Valle, Luis ^a   Darbinyan, Armine ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGNOPROTEIN; CAPSID PROTEIN; CYCLIN T1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN SUBUNIT; REGULATOR PROTEIN; SYNAPTOTAGMIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AIDS PATIENT; AMINO TERMINAL SEQUENCE; ARTICLE; ASTROCYTE; BINDING ASSAY; CELL NUCLEUS; CISTRON; CONTROLLED STUDY; CYTOPLASM; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; GLIA CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; JC VIRUS; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; RNA SEQUENCE; SUPERINFECTION; TRANSCRIPTION REGULATION; VIRUS CAPSID; VIRUS REPLICATION;

ASTROCYTES; BRAIN; CELL LINE, TUMOR; CELL NUCLEUS; GENE PRODUCTS, TAT; HIV LONG TERMINAL REPEAT; HUMANS; MODELS, GENETIC; NF-KAPPA B; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SP1 TRANSCRIPTION FACTOR; TRANSFECTION; VIRAL PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; JC POLYOMAVIRUS; MIRIDAE;

EID: 33748518394     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.02138-05     Document Type: Article

References (80)

1. Anderson, C. E., G. S. Tomlinson, B. Pauly, F. W. Brannan, A. Chiswick, R. Brack-Werner, P. Simmonds, and J. E. Bell. 2003. Relationship of Nef-positive and GFAP-reactive astrocytes to drug use in early and late HIV infection. Neuropathol. Appl. Neurobiol. 29:378-388.
2. Barboric, M., R. M. Nissen, S. Kanazawa, N. Jabrane-Ferrat, and B. M. Peterlin. 2001. NF-kappa B binds P-TEFb to stimulate transcriptional elongation by RNA polymerase II. Mol. Cell 8:327-337.
3. Beiniasz, P. D., T. A. Grdina, H. P. Bogerd, and B. R. Cullen. 1999. Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. USA 96:7791-7796.
4. Berger, J. R. 2003. Progressive multifocal leukoencephalopathy in acquired immunodeficiency syndrome: explaining the high incidence and disproportionate frequency of the illness relative to other immunosuppressive conditions. J. Neurovirol. 9(Suppl. 1):38-41.
5. Berger, J. R., and M. Concha. 1995. Progressive multifocal leukoencephalopathy: the evolution of a disease once considered rare. J. Neurovirol. 1:5-18.
6. Berger, J. R., B. Kaszovitz, M. J. Post, and G. Dickinson. 1987. Progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. A review of the literature with a report of sixteen cases. Ann. Intern. Med. 107:78-87.
7. Berger, J. R., A. Chauhan, D. Galey, and A. Nath. 2001. Epidemiological evidence and molecular basis of interactions between HIV and JC virus. J. Neurovirol. 7:329-338.
8. Berkhout, B., A. Gatignol, A. B. Rabson, and K. T. Jeang. 1990. TAR-independent activation of the HIV-1 LTR: evidence that tat requires specific regions of the promoter. Cell 62:757-767.
9. Brack-Werner, R. 1999. Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis. AIDS 13:1-22.
10. Chen, N. N., C.-F. Chang, G. L. Gallia, D. A. Kerr, E. M. Johnson, C. P. Krachmarov, S. M. Barr, R. J. Frisque, B. Bollag, and K. Khalili. 1995. Cooperative action of cellular proteins YB-1 and Pur alpha with the tumor antigen of the human JC polyomavirus determines their interaction with the viral lytic control element. Proc. Natl. Acad. Sci. USA 92:1087-1091.
11. Chepenik, L. G., A. P. Tretiakova, C. P. Krachmarov, E. M. Johnson, and K. Khalili. 1998. The single-stranded DNA binding protein, Purα, binds HIV-1 TAR RNA and activates HIV-1 transcription. Gene 210:37-44.
12. Chowdhury, M., J. P. Taylor, H. Tada, J. Rappaport, F. Wong-Staal, S. Amini, and K. Khalili. 1990. Regulation of the human neurotropic virus promoter by JCV-T-antigen and HIV-1 tat protein. Oncogene 5:1737-1742.
13. Chowdhury, M., J. P. Taylor, C.-F. Chang, J. Rappaport, and K. Khalili. 1992. Evidence that a sequence similar to TAR is important for induction of the JC virus late promoter by human immunodeficiency virus type 1 Tat. J. Virol. 66:7355-7361.
14. L, in cells derived from CNS. Oncogene 8:887-892.
15. Chun, R. F., O. J. Semmes, C. Neuveut, and K.-T. Jeang. 1998. Modulation of Sp1 phosphorylation by human immunodeficiency virus type 1 Tat. J. Virol. 72:2615-2629.
16. Cole, R., and J. de Vellis. 1997. Astrocyte and oligodendrocyte cultures, p. 117-130. In S. Federoff and A. Richardson (ed.), Protocols for neural cell culture, 2nd ed. Humana Press, Totowa, NJ.
17. Dandekar, D. H., K. N. Ganesh, and D. Mitra. 2004. HIV-1 Tat directly binds to NF kappaB enhancer sequence: role in viral and cellular gene expression. Nucleic Acids Res. 32:1270-1278.
18. Daniel, D. C., Y. Kinoshita, M. A. Khan, L. Del Valle, K. Khalili, J. Rappaport, and E. M. Johnson. 2004. Internalization of exogenous human immunodeficiency virus-1 protein, Tat, by KG-1 oligodendroglioma cells followed by stimulation of DNA replication initiated at the JC virus origin. DNA Cell Biol. 23:858-867.
19. Darbinian-Sarkissian, N., A. Darbinyan, J. Otte, S. Radhakrishnan, B. E. Sawaya, A. Arzumanyan, G. Chipitsyna, Y. Popov, J. Rappaport, S. Amini, and K. Khalili. 2006. p27SJ, a novel protein in St. John's Wort that suppresses expression of HIV-1 genome. Gene Ther. 13:288-295.
20. Darbinyan, A., N. Darbinian, M. Safak, S. Radhakrishnan, A. Giordano, and K. Khalili. 2002. Evidence for dysregulation of cell cycle by human polyomavirus, JCV, late auxiliary protein. Oncogene 21:5574-5581.
21. Darbinyan, A., K, M. Siddiqui, D. Slonina, N. Darbinian, S. Amini, M. K. White, and K. Khalili. 2004. Role of JC virus agnoprotein in DNA repair. J. Virol. 78:8593-8600.
22. Darfeuille, F, A. Arzumanov, S. Gryaznov, M. J. Gait, C. Di Primo, and J. J. Toulme. 2002. Loop-loop interaction of HIV-1 TAR RNA with N3′-P5′ deoxyphosphoramidate aptamers inhibits in vitro Tat-mediated transcription. Proc. Natl. Acad. Sci. USA 99:9709-9714.
23. Del Valle, L., S. Croul, S. Morgello, S. Amini, J. Rappaport, and K. Khalili. 2000. Detection of HIV-1 Tat and JCV capsid protein, VP1, in AIDS brain with progressive multifocal leukoencephalopathy. J. Neurovirol. 6:221-228.
24. Del Valle, L, J. Gordon, S. Enam, S. Delbue, S. Croul, S. Abraham, S. Radhakrishnan, M. Assimakopoulou, C. D. Katsetos, and K. Khalili. 2002. Expression of human neurotropic polyomavirus JCV late gene product agnoprotein in human medulloblastoma. J. Natl. Cancer Inst. 94:267-273.
25. Enam, S., T. M. Sweet, S. Amini, K. Khalili, and L. Del Valle. 2004. Evidence for involvement of transforming growth factor beta 1 signaling pathway in activation of JC virus in human immunodeficiency virus 1-associated progressive multifocal leukoencephalopathy. Arch. Pathol. Lab. Med. 128:282-291.
26. Fraldi, A., F. Varrone, G. Napolitano, A. A. Michels, B. Majello, O. Bensaude, and L. Lania. 2005. Inhibition of Tat activity by the HEXIM1 protein. Retrovirology 2:42.
27. Garber, M. E., T. P. Mayall, E. M. Suess, J. Meisenhelder, N. E. Thompson, and K. A. Jones. 2000. CDK9 autophosphorylation regulates high-affinity binding of the human immunodeficiency virus type 1 Tat-P-TEFb complex to TAR RNA. Mol. Cell. Biol. 20:6958-6969.
28. Garcia-Martinez, L. F., G. Mavankal, J. M. Neveu, W. S. Lane, D. Ivanov, and R. B. Gaynor. 1997. Purification of a Tat-associated kinase reveals a TFIIH complex that modulates HIV-1 transcription. EMBO J. 16:2836-2850.
29. Gendelman, H. E., W. Phelps, L. Feigenbaum, J. M. Ostrove, A. Adachi, P. M. Howley, G. Khoury, H. S. Ginsberg, and M. A. Martin. 1986. Transactivation of the human immunodeficiency virus long terminal repeat sequence by DNA viruses. Proc. Natl. Acad. Sci. USA 83:9759-9763.
30. Graham, F. L., and A. J. van der Eb. 1973. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology 52:456-467.
31. Harrich, D., J. Garcia, R. Mitsuyasu, and R. Gaynor. 1990. TAR-independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes. EMBO J. 9:4417-4423.
32. Jeang, K.-T., R. Chun, N. H. Lin, A. Gatignol, C. G. Glabe, and H. Fan. 1993. In vitro and in vivo binding of human immunodeficiency virus type 1 Tat protein and Sp1 transcription factor. J. Virol. 67:6224-6233.
33. Jones, K. A., and B. M. Peterlin. 1994. Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63:717-743.
34. Kashanchi, F., G. Piras, M. F. Radonovich, J. F. Duvall, A. Fattaey, C. M. Chiang, R. G. Roeder, and J. N. Brady. 1994. Direct interaction of human TFIID with the HIV-1 transactivator tat. Nature 367:295-299.
35. Khalili, K., M. K. White, H. Sawa, K. Nagashima, and M. Safak. 2004. The agnoprotein of polyomaviruses: a multifunctional auxiliary protein. J. Cell. Physiol. 207:1-7.
36. Kolb, G., S. Reigadas, C. Boiziau, A. van Aerschot, A. Arzumanov, M. J. Gait, P. Herdewijn, and J. J. Toulme. 2005. Hexitol nucleic acid-containing aptamers are efficient ligands of HIV-1 TAR RNA. Biochemistry 44:2926-2933.
37. Krachmarov, C. P., L. G. Chepenik, S. Barr-Vagell, K. Khalili, and E. M. Johnson. 1996. Activation of the JC virus Tat-responsive transcriptional control element by association of the Tat protein of human immunodeficiency virus 1 with cellular protein Pur alpha. Proc. Natl. Acad. Sci. USA 93:14112-14117.
38. Kwak, Y. T., D. Ivanov, J. Guo, E. Nee, and R. B. Gaynor. 1999. Role of the human and murine cyclin T proteins in regulating HIV-1 tat activation. J. Mol. Biol. 288:57-69.
39. McCarthy, M., J. He., and C. Wood. 1998. HIV-1 strain-associated variability in infection of primary neuroglia. J. Neurovirol. 4:80-89.
40. Michels, A. A., V. T. Nguyen, A. Fraldi, V. Labas, M. Edwards, F. Bonnet, I. Lania, and O. Bensaude. 2003. MAQ1 and 7SK RNA interaction with CDK9/cyclin T complexes in a transcription-dependent manner. Mol. Cell. Biol. 23:4859-4869.
41. Murchie, A. I., B. Davis, C. Isel, M. Afshar, M. J. Drysdale, J. Bower, A. J. Potter, I. D. Slarkey, T. M. Swarbrick, S. Mizra, C. D. Prescott, P. Vaglio, F. Aboul-ela, and J. Karn. 2004. Structure-based drug design targeting an inactive RNA conformation: exploiting the flexibility of HIV-1 TAR RNA. J. Mol. Biol. 336:625-638.
42. Nabel, G., and D. Baltimore. 1987. An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature 326:711-713. (Erratum, 344:178, 1990.)
43. Neumann, M., B. K. Felber, A. Kleinschmidt, B. Froese, V. Erfle, G. N. Pavlakis, and R. Brack-Werner. 1995. Restriction of human immunodeficiency virus type 1 production in a human astrocytoma cell line is associated with a cellular block in Rev function. J. Virol. 69:2159-2167.
44. Neumann, M., E. Afonina, F. Ceccherini-Silberstein, S. Schlicht, V. Erfle, G. N. Pavlakis, and R. Brack-Werner. 2001. Nucleocytoplasmic transport in human astrocytes: decreased nuclear uptake of the HIV Rev shuttle protein. J. Cell Sci. 114:1717-1729.
45. Nguyen, V. T., T. Kiss, A. A. Michels, and O. Bensaude. 2001. 7SK small nuclear RNA binds to and inhibits the activity of cdk9/cyclin T complexes. Nature 414:322-325.
46. Okada, Y., S. Endo, H. Takahashi, H. Sawa, T. Umemura, and K. Nagashima. 2001. Distribution and function of JCV agnoprotein. J. Neurovirol. 7:302-306.
47. Okada, Y., H. Sawa, S. Endo, Y. Orba, T. Umemura, H. Nishihara, A. C. Stan, S. Tanaka, H. Takahashi, and K. Nagashima. 2002. Expression of JCV Agnoprotein in progressive leukoencephalopathy brain. Acta Neuropathol. (Berlin) 104:130-136.
48. Okamoto, H., C. T. Sheline, J. L. Corden, K. A. Jones, and B. M. Peterlin. 1996. Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA 93:11575-11579.
49. Parada, C. A., and R. G. Roeder. 1996. Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature 384:375-378.
50. Petito, C. K., E. S. Cho, W. Lemann, B. A. Navia, and R. W. Price. 1986. Neuropathology of acquired immunodeficiency syndrome (AIDS): an autopsy review. J. Neuropathol. Exp. Neurol. 45:635-646.
51. Price, R. W., B. J. Brew, and M. Rosenblum. 1990. The AIDS dementia complex and HIV-1 brain infection: a pathogenetic model of virus-immune interaction, p. 269-290. In B. H. Waksman (ed.), Immunologic mechanisms in neurologic and psychiatric disease. Raven Press, New York, N.Y.
52. Radhakrishnan, S., J. Gordon, L. Del Valle, J. Cui, and K. Khalili. 2004. Intracellular approach for blocking JC virus gene expression by using RNA interference during viral infection. J. Virol. 78:7264-7269.
53. Safak, M., and K. Khalili. 2001. Physical and functional interaction between viral and cellular proteins modulate JCV gene transcription. J. Neurovirol. 7:288-292.
54. Safak, M., and K. Khalili. 2003. An overview: human polyomavirus, JC virus, and its associated disorders. J. Neurovirol. 9(Suppl. 1):3-9.
55. Safak, M., R. Barrucco, A. Darbinyan, Y. Okada, K. Nagashima, and K. Khalili. 2001. Interaction of JC virus Agno protein with T antigen modulates transcription and replication of the viral genome in glial cells. J. Virol. 75:1476-1486.
56. Safak, M., B. Sadowska, R. Barrucco, and K. Khalili. 2002. Functional interaction between JC virus late regulatory agnoprotein and cellular Y-box binding transcription factor, YB-1. J. Virol. 76:3828-3838.
57. Saito, Y., L. R. Sharer, L. G. Epstein, J. Michaels, M. Mintz, M. Louder, K. Golding, T. A. Cvetkovich, and B. M. Blumberg. 1994. Overexpression of nef as a marker for restricted HIV-1 infection of astrocytes in postmortem pediatric central nervous tissue. Neurology 44:474-481.
58. Sawaya, B. E., K. Khalili, J. Gordon, R. Taube, and S. Amini. 2000. Cooperative interaction between HIV-1 regulatory proteins Tat and Vpr modulates transcription of the viral genome. J. Biol. Chem. 275:35209-35214.
59. Tada, H., J. Rappaport, M. Lashgari, S. Amini, F. Wong-Stahl, and K. Khalili. 1990. Trans-activation of the JC virus late promoter by the tat protein of type 1 human immunodeficiency virus in glial cells. Proc. Natl. Acad. Sci. USA 87:3479-3483.
60. Takahashi, K., S. L. Wesselingh, D. E. Griffin, J. C. McArthur, R. T. Johnson, and J. D. Glass. 1996. Localization of HIV-1 in human brain using polymerase chain reaction/in situ hybridization and immunocytochemistry. Ann. Neurol. 39:705-711.
61. Taylor, J. P., and K. Khalili. 1994. Activation of HIV-1 transcription by Tat in cells derived from the CNS: evidence for the participation of NF-kappaB. Adv. Neuroimmunol. 4:291-303.
62. Taylor, J. P., R. Pomerantz, O. Bagasra, M. Chowdhury, J. Rappaport, K. Khalili, and S. Amini. 1992. TAR-independent transactivation by Tat in cells derived from the CNS: a novel mechanism of HIV-1 gene regulation. EMBO J. 11:3395-3403.
63. Taylor, J. P., M. Kundu, and K. Khalili. 1993. TAR-independent activation of HIV-1 requires the activation domain but not the RNA-binding domain of Tat. Virology 195:780-785.
64. Taylor, J. P., R. J. Pomerantz, G. Raj, F. Kashanchi, J. N. Brady, S. Amini, and K. Khalili. 1994. Central nervous system-derived cells express a κB-binding activity that enhances human immunodeficiency virus type 1 transcription in vitro and facilitates TAR-independent transactivation by Tat. J. Virol. 68:3971-3981.
65. Tornatore, C., R. Chandra, J. R. Berger, and E. O. Major. 1994. HIV-1 infection of subcortical astrocytes in the pediatric central nervous system. Neurology 44:481-487.
66. Trillo-Pazos, G., A. Diamanturos, L. Rislove, T. Menza, W. Chao, P. Belem, S. Sadiq, S. Morgello, L. Sharer, and D. J. Volsky. 2003. Detection of HIV-1 DNA in microglia/macrophages, astrocytes, and neurons isolated from brain tissue with HIV-1 encephalitis by laser capture microdissection. Brain Pathol. 13:144-154.
67. Vacante, D. A., R. Traub, and E. O. Major. 1989. Extension of JC virus host range to monkey cells by insertion of a simian virus 40 enhancer into the JC virus regulatory region. Virology 170:353-361.
68. Walker, D. L. 1985. Progressive multifocal leukoencephalopathy, p. 503-524. In P. J. Vinken, G. W. Bruyn, H. L. Klawans, and J. C. Kloetsier (ed.), Handbook of clinical neurology, vol. 47. Elsevier, New York, N.Y.
69. Wei, P., M. E. Garber, S. M. Fang, W. H. Fischer, and K. A. Jones. 1998. A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell 92:451-462.
70. West, M. J., A. D. Lowe, and J. Karn. 2001. Activation of human immunodeficiency virus transcription in T cells revisited: NF-κB p65 stimulates transcriptional elongation. J. Virol. 75:8524-8537.
71. Westendorp, M. O., V. A. Shatrov, K. Schulze-Osthoff, R. Frank, M. Kraft, M. Los, P. H. Krammer, W. Dröge, and V. Lehmann. 1995. HIV-1 Tat potentiates TNF-induced NF-kappaB activation and cytotoxicity by altering the cellular redox state. EMBO J. 14:546-554.
72. White, S. M., M. Renda, N.-Y. Nam, E. Klimatcheva, Y. Zhu, J. Fisk, M. Halterman, B. J. Rimel, H. Federoff, S. Pandya, J. D. Rosenblatt, and V. Planelles. 1999. Lentivirus vectors using human and simian immunodeficiency virus elements. J. Virol. 73:2832-2840.
73. Wright, C. M., B. K. Felber, H. Paskalis, and G. N. Pavlakis. 1986. Expression and characterization of the transactivator of HTLV-III/LAV virus. Science 234:988-992.
74. Yamamoto, R., M. Katahira, S. Nishikawa, T. Baba, K. Taira, and P. K. Kumar. 2000. A novel RNA motif that binds efficiently and specifically to the Tat protein of HIV and inhibits the transactivation by Tat of transcription in vitro and in vivo. Genes Cells 5:371-388.
75. Yang, L., G. F. Morris, J. M. Lockyer, M. Lu, Z. Wang, and C. B. Morris. 1997. Distinct transcriptional pathways of TAR-dependent and TAR-independent human immunodeficiency virus type-1 transactivation by Tat. Virology 235:48-64.
76. Yang, Z., Q. Zhu, K. Luo, and Q. Zhou. 2001. The 7SK small nuclear RNA inhibits the cdk9/cyclin T1 kinase to control transcription. Nature 414:317-322.
77. Yedavalli, V. S. R. K., M. Benkirane, and K. T. Jeang. 2003. Tat and trans-activation-responsive (TAR) RNA-independent induction of HIV-1 long terminal repeat by human and murine cyclin T1 requires Sp1. J. Biol. Chem. 278:6404-6410.
78. Yik, J. H., R. Chen, R. Nishimura, J. L. Jennings, A. J. Link, and Q. Zhou. 2003. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell 12:971-982.
79. Yong, V. W., and J. P. Antel. 1997. Culture of neural cells from human brain biopsies, p. 81-96. In S. Federoff and A. Anderson (ed.), Protocols for neural cell culture. Humana Press, Totowa, N.J.
80. Zhu, Y., T. Pe'ery, J. Peng, Y. Ramanathan, N. Marshall, T. Marshall, B. Amendt, M. B. Mathews, and D. H. Price. 1997. Transcription elongation factor P-TEFb is required for HIV-1 Tat transactivation in vitro. Genes Dev. 11:2622-2632.